vs
Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $60.1M, roughly 1.7× RHYTHM PHARMACEUTICALS, INC.). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — -1.4% vs -92.6%, a 91.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 3.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs 12.0%).
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
GDYN vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $104.1M | $60.1M |
| Net Profit | $-1.5M | $-55.6M |
| Gross Margin | 34.8% | 88.1% |
| Operating Margin | 61.7% | -87.1% |
| Net Margin | -1.4% | -92.6% |
| Revenue YoY | 3.7% | 83.8% |
| Net Profit YoY | -150.6% | — |
| EPS (diluted) | $-0.02 | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $104.1M | $60.1M | ||
| Q4 25 | $106.2M | $57.3M | ||
| Q3 25 | $104.2M | $51.3M | ||
| Q2 25 | $101.1M | $48.5M | ||
| Q1 25 | $100.4M | $32.7M | ||
| Q4 24 | $100.3M | $41.8M | ||
| Q3 24 | $87.4M | $33.3M | ||
| Q2 24 | $83.0M | $29.1M |
| Q1 26 | $-1.5M | $-55.6M | ||
| Q4 25 | $306.0K | $-47.5M | ||
| Q3 25 | $1.2M | $-52.9M | ||
| Q2 25 | $5.3M | $-46.6M | ||
| Q1 25 | $2.9M | $-49.5M | ||
| Q4 24 | $4.5M | $-43.3M | ||
| Q3 24 | $4.3M | $-43.6M | ||
| Q2 24 | $-817.0K | $-32.3M |
| Q1 26 | 34.8% | 88.1% | ||
| Q4 25 | 34.0% | 91.6% | ||
| Q3 25 | 33.3% | 89.3% | ||
| Q2 25 | 34.1% | 88.6% | ||
| Q1 25 | 36.8% | 88.8% | ||
| Q4 24 | 36.9% | 90.9% | ||
| Q3 24 | 37.4% | 88.5% | ||
| Q2 24 | 35.6% | 89.9% |
| Q1 26 | 61.7% | -87.1% | ||
| Q4 25 | 0.5% | -82.2% | ||
| Q3 25 | -0.2% | -102.6% | ||
| Q2 25 | -0.1% | -93.4% | ||
| Q1 25 | -2.0% | -143.7% | ||
| Q4 24 | 1.3% | -98.6% | ||
| Q3 24 | 2.4% | -132.0% | ||
| Q2 24 | 0.0% | -139.2% |
| Q1 26 | -1.4% | -92.6% | ||
| Q4 25 | 0.3% | -83.0% | ||
| Q3 25 | 1.1% | -103.1% | ||
| Q2 25 | 5.2% | -96.1% | ||
| Q1 25 | 2.9% | -151.4% | ||
| Q4 24 | 4.5% | -103.6% | ||
| Q3 24 | 4.9% | -131.2% | ||
| Q2 24 | -1.0% | -110.9% |
| Q1 26 | $-0.02 | $-0.83 | ||
| Q4 25 | $0.01 | $-0.73 | ||
| Q3 25 | $0.01 | $-0.82 | ||
| Q2 25 | $0.06 | $-0.75 | ||
| Q1 25 | $0.03 | $-0.81 | ||
| Q4 24 | $0.06 | $-0.71 | ||
| Q3 24 | $0.05 | $-0.73 | ||
| Q2 24 | $-0.01 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $327.5M | $340.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $530.1M | $122.9M |
| Total Assets | $605.0M | $442.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $327.5M | $340.6M | ||
| Q4 25 | $342.1M | $388.9M | ||
| Q3 25 | $338.6M | $416.1M | ||
| Q2 25 | $336.8M | $291.0M | ||
| Q1 25 | $325.5M | $314.5M | ||
| Q4 24 | $334.7M | $320.6M | ||
| Q3 24 | $231.3M | $298.4M | ||
| Q2 24 | $256.0M | $319.1M |
| Q1 26 | $530.1M | $122.9M | ||
| Q4 25 | $542.1M | $139.1M | ||
| Q3 25 | $537.7M | $148.8M | ||
| Q2 25 | $532.2M | $-11.9M | ||
| Q1 25 | $517.4M | $18.9M | ||
| Q4 24 | $517.8M | $21.7M | ||
| Q3 24 | $400.2M | $11.2M | ||
| Q2 24 | $388.4M | $39.3M |
| Q1 26 | $605.0M | $442.3M | ||
| Q4 25 | $612.9M | $480.2M | ||
| Q3 25 | $613.2M | $506.9M | ||
| Q2 25 | $608.9M | $372.7M | ||
| Q1 25 | $590.9M | $386.7M | ||
| Q4 24 | $592.2M | $392.3M | ||
| Q3 24 | $477.3M | $363.6M | ||
| Q2 24 | $443.6M | $381.8M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
